Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research Team Invents Small-Diameter Artificial Arteries

04.03.2005


A patient needs a small-diameter bypass graft to replace a diseased blood vessel because of the progression of diabetes or the result of smoking.



Due to these chronic health issues, the patient’s veins can no longer be used for such a procedure. While large artificial arteries (10 to 15 millimeters in diameter) have been in use for about 50 years for replacing large blood vessels, development of a small-diameter artificial artery (less than 5 millimeters) has been unsuccessful due to rapid failure when implanted.

Martin Bide, a textile chemist at the University of Rhode Island, Matthew Phaneuf, president of BioSurfaces, Ashland, Mass., and Philip J. Brown of the School of Materials Science and Engineering at Clemson University, have developed a new way to synthesize such grafts from material made of polyester and collagen. A Phase I Small Business Innovative Research Grant (SBIR) from the National Heart, Lung and Blood Institute from the National Institutes of Health funded the research.


The trio said in its research summary that more than 500,000 peripheral bypass and coronary artery bypass grafts are implanted in the United States annually, so the potential annual market for a synthetic bypass graft could exceed $1.5 billion. Up until the team’s work, very little had changed with the technology related to artificial arteries since the mid-1950s, according to Phaneuf.

The polyester and collagen are electrospun into a mesh of ultra-fine fibers. Electrospinning uses electrostatic forces to distort a droplet of polymer solution into a fine filament to be deposited onto a surface. The process allows production of novel synthetic fibers of unusually small diameter and good mechanical properties. Other potential applications include wound dressing materials, artificial organs, and protective clothing. The researchers say the collagen allows the attachment of bioactive proteins that will promote healing and reduce clot formation.

Currently, no clinically available small (5 millimeter in diameter and smaller) vascular grafts can emulate the biological and physical properties of normal arteries. Implanted grafts of currently available materials fail because of clotting and stiffness as related to normal blood vessels. “A small vessel prosthesis (artery graft) that better emulates normal arterial walls would greatly improve the treatment of both peripheral vascular disease and coronary artery disease,” the researchers state in a summary of their research. “This is one of the applications it suits perfectly since conventional fiber extrusion technology is incapable of making such a material i.e., one that can combine proteins and synthetic materials together to form a composite small- scale device with all the right kind of properties,” Brown said.

The technology developed by Phaneuf, Brown and Bide is called “a nanofibrous biocomposite prosthetic vascular graft.” “The first choice for such a procedure is a patient’s own veins,” Bide said, “but when those veins have been damaged as a result of chronic illness, such as diabetes or those conditions related to smoking, then surgeons need an alternative.” “We employ the electrospinning process to create nanofibers with very large surface area for their weight,” Phaneuf said.

Bide said the collagen will be eliminated as the body’s own cells take up spaces in the artery or graft, thus reducing the potential for rejection. “We know through our early research that we can link proteins to the grafts and add anti-clotting treatments, as well as growth factors and other bioactive agents,” Bide said.

The next step for the three researchers, after successful completion of the Phase II SBIR studies, is to find a private company interested in licensing the product to allow for further research and eventual production for the market. “As a scientist, you always want to see an invention fully developed so that it can be used to help people,” Phaneuf said.

| newswise
Further information:
http://www.uri.edu

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>